Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome

(1) Background: We aimed to explore the associations between menopause, postmenopausal hormone therapy, and metabolic syndrome in a large community-based group of Asian women. (2) Methods: This is a cross-sectional study in which we enrolled women aged 30 to 70 years with sufficient information about menopausal status from the Taiwan Biobank. The definition for metabolic syndrome used in this study aligns with the Bureau of Health Promotion’s (Taiwan) proposed definition. (3) Results: A total of 17,460 women were recruited. The postmenopausal group had a higher metabolic syndrome prevalence (30% vs. 14%) and 1.17 times higher odds ratio (OR) than the premenopausal group (95% confidence interval [CI] = 1.02 to 1.33). Regarding the types of menopause, surgical menopause was associated with metabolic syndrome (OR = 1.40; 95% CI = 1.20 to 1.63); however, natural menopause was not associated with metabolic syndrome. Interestingly, postmenopausal hormone therapy was associated with a lower risk of metabolic syndrome in the women with natural menopause (OR = 0.79; 95% CI = 0.70 to 0.89), but not in those with surgical menopause. (4) Conclusions: Our results suggest that menopause is associated with an increased prevalence of metabolic syndrome, while postmenopausal hormone therapy is associated with a lower prevalence of metabolic syndrome in women with natural menopause.

[1]  M. Martínez-González,et al.  Coffee Consumption and the Risk of Metabolic Syndrome in the ‘Seguimiento Universidad de Navarra’ Project , 2023, Antioxidants.

[2]  Shu-Pin Huang,et al.  The association between menopause, postmenopausal hormone therapy, and kidney stone disease in Taiwanese women. , 2022, Annals of epidemiology.

[3]  J. Manson,et al.  Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study , 2022, EBioMedicine.

[4]  R. Muga,et al.  Prevalence and associations of metabolic syndrome in patients with alcohol use disorder , 2022, Scientific Reports.

[5]  Shu-Pin Huang,et al.  Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study , 2021, Journal of Personalized Medicine.

[6]  C. Kuo,et al.  Secondhand smoke increases the risk of developing kidney stone disease , 2021, Scientific Reports.

[7]  Rayyan Al Ali,et al.  Metabolic Syndrome Associated with Tobacco and Caffeine Products Use Among Refugee Adolescents: Risk of Dyslipidemia , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[8]  Maya B. Mathur,et al.  Menopausal hormone therapy and women’s health: An umbrella review , 2021, PLoS medicine.

[9]  H. Hasan,et al.  The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging. , 2020, Menopause.

[10]  Juan Antonio López-Rivera,et al.  The Impact of Education and Age on Metabolic Disorders , 2020, Frontiers in Public Health.

[11]  B. Yildizhan,et al.  The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms , 2020 .

[12]  N. Cherbuin,et al.  Lipid profile differences during menopause: a review with meta-analysis. , 2019, Menopause.

[13]  Sang Min Park,et al.  Associations of postmenopausal hormone therapy with metabolic syndrome among diabetic and non-diabetic women. , 2019, Maturitas.

[14]  M. Qorbani,et al.  Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies , 2018, Menopause.

[15]  Hwan-Sik Hwang,et al.  Relationship between Marital Status and Metabolic Syndrome in Korean Middle-Aged Women: The Sixth Korea National Health and Nutrition Examination Survey (2013–2014) , 2018, Korean journal of family medicine.

[16]  A. Mahajan,et al.  The Metabolic Syndrome and Menopause , 2018, Journal of mid-life health.

[17]  M. Saklayen.  The Global Epidemic of the Metabolic Syndrome , 2018, Current Hypertension Reports.

[18]  Kuan-Hung Lin,et al.  β‐Cell function in postmenopausal women with isolated post‐challenge hyperglycemia , 2018, Journal of diabetes.

[19]  Jie Wu,et al.  Metabolic syndrome in menopause and associated factors: a meta-analysis , 2017, Climacteric : the journal of the International Menopause Society.

[20]  E. Morselli,et al.  The effects of oestrogens and their receptors on cardiometabolic health , 2017, Nature Reviews Endocrinology.

[21]  S. Pelloso,et al.  Prevalence of metabolic syndrome in pre- and postmenopausal women , 2017, Archives of endocrinology and metabolism.

[22]  F. Mauvais-Jarvis,et al.  Effect of menopausal hormone therapy on components of the metabolic syndrome , 2017, Therapeutic advances in cardiovascular disease.

[23]  A. Vishnu,et al.  Progression of Metabolic Syndrome Severity During the Menopausal Transition , 2016, Journal of the American Heart Association.

[24]  C. Guerra-Araiza,et al.  Metabolism Regulation by Estrogens and Their Receptors in the Central Nervous System Before and After Menopause , 2016, Hormone and Metabolic Research.

[25]  B. Challacombe,et al.  Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross‐sectional, UK epidemiological study , 2016, BJU international.

[26]  N. Panay,et al.  2016 IMS Recommendations on women’s midlife health and menopause hormone therapy , 2016, Climacteric : the journal of the International Menopause Society.

[27]  M. Lumsden,et al.  Diagnosis and management of menopause: summary of NICE guidance , 2015, BMJ : British Medical Journal.

[28]  A. Stuebe.  Does breastfeeding prevent the metabolic syndrome, or does the metabolic syndrome prevent breastfeeding? , 2015, Seminars in perinatology.

[29]  G. Stachowiak,et al.  Metabolic disorders in menopause , 2015, Przeglad menopauzalny = Menopause review.

[30]  F. Azizi,et al.  Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study , 2015, Journal of Endocrinological Investigation.

[31]  G. Prasad,et al.  Metabolic syndrome and chronic kidney disease: Current status and future directions. , 2014, World journal of nephrology.

[32]  N. Suganuma,et al.  Prevalence and predictors of metabolic syndrome among Congolese pre- and postmenopausal women , 2014, Climacteric : the journal of the International Menopause Society.

[33]  Karimov Abdusamat Ismonovich,et al.  Effect of γ , 2013 .

[34]  Md. Mizanur Rahman,et al.  Higher Gravidity and Parity Are Associated with Increased Prevalence of Metabolic Syndrome among Rural Bangladeshi Women , 2013, PloS one.

[35]  A. Marjani,et al.  The Metabolic Syndrome among Postmenopausal Women in Gorgan , 2012, International journal of endocrinology.

[36]  S. Reis,et al.  Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation , 2011, Menopause.

[37]  M. Rattanachaiyanont,et al.  Predictors for metabolic syndrome in perimenopausal and postmenopausal Thai women , 2011, Climacteric : the journal of the International Menopause Society.

[38]  K. Rabiei,et al.  Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study , 2010, Diabetology & metabolic syndrome.

[39]  J. A. F. Figueiredo Neto,et al.  Metabolic syndrome and menopause: cross-sectional study in gynecology clinic. , 2010, Arquivos brasileiros de cardiologia.

[40]  P. Galvankar,et al.  Menopause and metabolic syndrome: A study of 498 urban women from western India , 2010, Journal of mid-life health.

[41]  X. Ruan,et al.  The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it , 2010, Menopause.

[42]  A. Esteghamati,et al.  Menopause is an independent predictor of metabolic syndrome in Iranian women. , 2010, Maturitas.

[43]  J. Salmerón,et al.  Physical activity and risk of Metabolic Syndrome in an urban Mexican cohort , 2009, BMC public health.

[44]  Ç. Çelik,et al.  Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[45]  A. Hajeer,et al.  Hormone therapy for endometriosis and surgical menopause. , 2009, The Cochrane database of systematic reviews.

[46]  R. Dias,et al.  Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women , 2009, Climacteric : the journal of the International Menopause Society.

[47]  G. Sypniewska,et al.  Adiponectin and Metabolic Syndrome in Women at Menopause , 2009, EJIFCC.

[48]  S. Crawford,et al.  Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. , 2008, Archives of internal medicine.

[49]  S. Tonstad,et al.  Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). , 2008, Gynecologic oncology.

[50]  R. Lobo.  Metabolic syndrome after menopause and the role of hormones. , 2008, Maturitas.

[51]  M. Vitolins,et al.  Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women , 2007, Nutrition journal.

[52]  P. Mirmiran,et al.  Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). , 2007, Maturitas.

[53]  D. Kim,et al.  Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation definition and the new abdominal obesity criteria for the Korean people. , 2007, Diabetes research and clinical practice.

[54]  E. Salpeter,et al.  Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women , 2006, Diabetes, obesity & metabolism.

[55]  S. Weisnagel,et al.  The WHO and NCEP/ATPIII Definitions of the Metabolic Syndrome in Postmenopausal Women: Are They So Different? , 2006, Metabolic syndrome and related disorders.

[56]  P. Chedraui,et al.  The metabolic syndrome among postmenopausal women in Ecuador , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[57]  K. Reynolds,et al.  Epidemiology of the Metabolic Syndrome , 2005, The American journal of the medical sciences.

[58]  A. Kraja,et al.  An evaluation of the metabolic syndrome in a large multi-ethnic study: the Family Blood Pressure Program , 2005, Nutrition & metabolism.

[59]  S. Chuang,et al.  Prevalence of metabolic syndrome in a large health check-up population in Taiwan. , 2004, Journal of the Chinese Medical Association : JCMA.

[60]  J. Lidfeldt,et al.  Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women’s Health in the Lund Area study , 2004, Menopause.

[61]  E. Ford.  Prevalence of the metabolic syndrome in US populations. , 2004, Endocrinology and metabolism clinics of North America.

[62]  B. Balkau,et al.  The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. , 2003, Diabetes & metabolism.

[63]  M. C. Carr,et al.  The emergence of the metabolic syndrome with menopause. , 2003, The Journal of clinical endocrinology and metabolism.

[64]  Ambady Ramachandran,et al.  Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. , 2003, Diabetes research and clinical practice.

[65]  Shankuan Zhu,et al.  The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of internal medicine.

[66]  J. Meigs.  Epidemiology of the metabolic syndrome, 2002. , 2002, The American journal of managed care.

[67]  S. Tsai,et al.  The impact of years since menopause on the development of impaired glucose tolerance. , 2001, Journal of clinical epidemiology.

[68]  M. Moroi,et al.  Prevalence of metabolic syndrome among rural Bangladeshi women. , 2012, Diabetes research and clinical practice.

[69]  J. Reckelhoff,et al.  Postmenopausal hypertension. , 2011, American journal of hypertension.

[70]  R. Heshmat,et al.  Metabolic syndrome and menopause: A population-based study , 2010 .

[71]  A. Sharma,et al.  Prevalence of cardiovascular risk factors in postmenopausal women: A rural study , 2010, Journal of mid-life health.

[72]  S. Lai,et al.  Prevalence of metabolic syndrome in Taiwanese adults: a hospital-based study , 2006, Annals of Saudi medicine.

[73]  R. Califf,et al.  Metabolic syndrome: definition, pathophysiology, and mechanisms. , 2005, American heart journal.

[74]  Robert J Lipsy,et al.  The National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2003, Journal of managed care pharmacy : JMCP.